Lupin acquires Russian drug firm Biocom
India's fifth largest drug maker Lupin has acquired a 100% stake in Biocom, a fast-growing generic pharmaceuticals firm in Russia. This is Lupin's second overseas acquisition this year, the first being Brazil's Medquimica that Lupin acquired in May 2015.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
